Vol 7, No 4 (August 2016): Journal of Gastrointestinal Oncology

Original Article

Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience
Humaid O. Al-Shamsi, Yazan Fahmawi, Ibrahim Dahbour, Aziz Tabash, Jane E. Rogers, Jeannette Elizabeth Mares, Mariela A. Blum, Jeannelyn Estrella, Aurelio Matamoros Jr, Tara Sagebiel, Catherine E. Devine, Brian D. Badgwell, Quan D. Lin, Prajnan Das, Jaffer A. Ajani
Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience
Elizabeth Won, Manish A. Shah, Heiko Schöder, Vivian E. Strong, Daniel G. Coit, Murray F. Brennan, David P. Kelsen, Yelena Y. Janjigian, Laura H. Tang, Marinela Capanu, Nabil P. Rizk, Peter J. Allen, Manjit S. Bains, David H. Ilson
Esophagojejunal anastomosis leakage after total gastrectomy for esophagogastric junction adenocarcinoma: options of treatment
Fabio Carboni, Mario Valle, Orietta Federici, Giovanni Battista Levi Sandri, Ida Camperchioli, Rocco Lapenta, Daniela Assisi, Alfredo Garofalo
Hyperthermic intraperitoneal chemotherapy (HIPEC) and neoadjuvant chemotherapy as prophylaxis of peritoneal carcinosis from advanced gastric cancer—effects on overall and disease free survival
Federico Coccolini, Andrea Celotti, Marco Ceresoli, Giulia Montori, Michele Marini, Fausto Catena, Luca Ansaloni
Administered activity and outcomes of glass versus resin 90Y microsphere radioembolization in patients with colorectal liver metastases
Shyam M. Srinivas, Elie C. Nasr, Vamsi K. Kunam, Jennifer A. Bullen, Andrei S. Purysko
Clinical outcomes of pancreaticoduodenectomy in octogenarians: a surgeon’s experience from 2007 to 2015
Diana H. Liang, Beverly A. Shirkey, Wade R. Rosenberg, Sylvia Martinez
Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer
Eric A. Mellon, Tobin J. Strom, Sarah E. Hoffe, Jessica M. Frakes, Gregory M. Springett, Pamela J. Hodul, Mokenge P. Malafa, Michael D. Chuong, Ravi Shridhar
BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype
Humaid O. Al-Shamsi, Deepa Anand, Rachna T. Shroff, Apurva Jain, Mingxin Zuo, Claudius Conrad, Jean-Nicolas Vauthey, Milind M. Javle
Outcomes in patients with brain metastasis from esophageal carcinoma
Nishi Kothari, Eric Mellon, Sarah E. Hoffe, Jessica Frakes, Ravi Shridhar, Jose Pimiento, Ken Meredith, Nam D. Tran, Nadia Saeed, Khaldoun Almhanna
A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma
Shaffer R. S. Mok, Sachin Mohan, Navjot Grewal, Adam B. Elfant, Thomas A. Judge
Comparison of external beam radiation and brachytherapy to external beam radiation alone for unresectable extrahepatic cholangiocarcinoma
Dustin Boothe, Zachary Hopkins, Jonathan Frandsen, Shane Lloyd
Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma
Matthias Unseld, Werner Scheithauer, Roman Weigl, Gabriela Kornek, Nadja Stranzl, Daniela Bianconi, Georg Brunauer, Guenther Steger, Christoph C. Zielinski, Gerald W. Prager
Comparative effectiveness of chemopreventive interventions for colorectal cancer: protocol for a systematic review and network meta-analysis of randomised controlled trials
Sajesh K. Veettil, Surasak Saokaew, Kean Ghee Lim, Siew Mooi Ching, Pochamana Phisalprapa, Nathorn Chaiyakunapruk
Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome
Mahshid Jalilian, Sidney Davis, Mohammadreza Mohebbi, Bhuvana Sugamaran, Ian W. Porter, Stephen Bell, Satish K. Warrier, Roger Wale
Association between chronic hepatitis C and hepatitis C/HIV co-infection and the development of colorectal adenomas
Jorge Hurtado-Cordovi, Ashley H. Davis-Yadley, Seth Lipka, Magdalene Vardaros, Huafeng Shen
The prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: the influence of liver fibrosis
Masayoshi Yada, Masayuki Miyazaki, Kenta Motomura, Akihide Masumoto, Makoto Nakamuta, Motoyuki Kohjima, Rie Sugimoto, Yoshifusa Aratake, Nobuhiko Higashi, Shusuke Morizono, Shinichiro Takao, Naoki Yamashita, Takeaki Satoh, Shinsaku Yamashita, Masami Kuniyoshi, Kazuhiro Kotoh
Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib
Anant Ramaswamy, Deepak Jain, Arvind Sahu, Joydeep Ghosh, Priya Prasad, Kedar Deodhar, Nitin Shetty, Shripad Banavali, Shailesh Shrikhande, Vikas Ostwal
Treatment of non-resectable and metastatic gastrointestinal stromal tumors: experience with the use of tyrosine kinase inhibitors in a third level hospital in Mexico
Abdel Karim Dip Borunda, Alberto Pimentel Renteria, Miguel Pluma Jiménez, Mario Pérez Martínez, Gloria Martínez Martínez, Samuel Rivera Rivera, Rocío Grajales Álvarez, Yolanda Bautista Aragón, Miguel Quintana Quintana, Juan Alejandro Silva
Pazopanib in metastatic multiply treated progressive gastrointestinal stromal tumors: feasible and efficacious
Anant Ramaswamy, Nikhil Pande, Omshree Shetty, Nitin Shetty, Sudeep Gupta, Vikas Ostwal
Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review
Vivek Verma, Steven H. Lin, Charles B. Simone II, Minesh P. Mehta
A comparison between 5-fluorouracil/mitomycin and capecitabine/mitomycin in combination with radiation for anal cancer
Renata D’Alpino Peixoto, Dante D. Wan, Devin Schellenberg, Howard J. Lim

Case Report

Sarcoid reaction: a rare occurrence associated to colon adenocarcinoma (case report and literature review)
Cristina Díaz del Arco, M. Jesús Fernández Aceñero
Breast metastasis from recurrent gallbladder adenocarcinoma: a case report with review of the literature
Lamiae EL Amarti, Houssin Faouzi, Nariman Salmi, Hamza Ettahri, Ibrahim Elghissassi, Hind Mrabti, Hassan Errihani